Epbriv 0.44mg/ml (Eribulin Mesylate Vials) 0.44mg

Epbriv 0.44mg/ml (Eribulin Mesylate) is a chemotherapy solution for metastatic breast cancer treatment. Administered via infusion, it targets cancer cells to slow progression. This vial form is designed for clinical use under medical supervision. Store at room temperature away from light.

Strength

0.44mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Hetro pharmaceutical

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Epbriv 0.44mg/ml is used to treat metastatic breast cancer in adults who have previously received other chemotherapy treatments. It belongs to a class of drugs called microtubule inhibitors, which work by stopping cancer cells from dividing and growing. This medication is typically used when other treatments have not been effective. Patients may ask, 'what is Epbriv 0.44mg/ml used for' to understand its role in cancer care.

Side Effects

Epbriv 0.44mg/ml may cause common side effects such as fatigue, nausea, or hair loss. Some patients experience numbness or tingling in hands and feet due to its effects on nerve function. These effects vary by individual and are typically monitored during treatment. Regular blood tests help assess how the body responds to the medication.

Precautions & Warnings

Epbriv 0.44mg/ml should only be handled and administered by healthcare professionals in a clinical setting. Patients must inform their doctor about all medications, supplements, and medical conditions before starting treatment. Avoid exposure to sunlight and use protective measures if handling the vial. Keep out of reach of children and pets.

Avoid Interactions

Epbriv 0.44mg/ml may interact with other drugs that affect liver enzymes, such as certain antibiotics or antifungals. Combining it with medications that cause drowsiness or affect blood counts could increase side effects. Alcohol and herbal supplements should be used cautiously. Always disclose all medications to your healthcare provider.

Frequently Asked Questions

Epbriv 0.44mg/ml is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common side effects include fatigue, nausea, hair loss, and numbness or tingling in hands and feet.

No, this medication must be administered by a healthcare provider in a controlled medical environment.

Epbriv 0.44mg/ml is used to slow the progression of metastatic breast cancer but is not a cure.

Store the vials at room temperature, away from light and moisture, and keep them out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.